Biogaia Signs Agreement With Novartis Consumer Health SA

Biogaia Signs Agreement With Novartis Consumer Health SA BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland, giving Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Forbes Medi-Tech Announces Reducol(tm) Based Products Available Next Week at Tesco Stores Ltd Company announces that Tesco Stores Ltd will start selling a range of products including a margarine spread, yogurt, and yogurt drink incorporating Forbes Medi-Tech's cholesterol-lowering ingredient, Reducol(tm) sometime next week. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Bioriginal Extends Flavored EFA Oil Portfolio Bioriginal’s comprehensive portfolio of essential fatty acid (EFA) based products has been extended with a new improved range of flavored omega-3, 6 and 9 oils - the oils are available in a delicious range of fruity, nutty or spice-based flavors. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Indena's Cosmetic Fluid Extract Lines to Move to Greentech Indena has disclosed today a preliminary agreement to transfer its cosmetic fluid extract lines, including its brands PHYTELENES® and COSMELENE®, to the French phytocosmetic specialists Greentech S.A.. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Navamedic Establishes Chitin Production in Northern Norway Navamedic has today entered into a long term agreement with Norwegian seafood company Nergård Group and will establish a chitin production facility at Senjahopen, Norway as it takes a step towards becoming a vertically integrated player in the European glucosamine industry. Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients. Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients. Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients. Tate & Lyle Announces Completion of Acquisition of US Ingredients Company Continental Custom Ingredients Company announces the completion of the previously announced acquisition of the US specialty food ingredients company Continental Custom Ingredients. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. LycoRed Launches New Corporate Image LycoRed has announced corporate image redesign as a part of its global strategy to strengthen its market presence, including a new company logo, website, and other marketing materials. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. Vitiva Launches URSOLE(TM) for Supplements and Cosmetics Applications URSOLE™, produced in a technologically-innovative extraction process from selected fresh rosemary leaves, contains 45% ursolic acid and its isomer oleanolic acid, and has been developed for the dietary supplements and cosmeceutical markets. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. New Clinical Trial on Saw Palmetto Inconsistent with Positive Results in Previous Studies The results of a new clinical trial on the popular herb saw palmetto may confuse the public, especially men with prostate problems, according to the American Botanical Council (ABC). Mark Blumenthal, Founder and Executive Director of ABC notes, that the study appears to have been well desgined, but expressed concern that men in this trial experienced moderate to severe symptoms of BPH, although most of the previous controlled trials showing positive results and efficacy for saw palmetto were conducted on men with mild to moderate symptoms of BPH. In examining serious adverse events, ABC notes that there were twice as many serious adverse events in the placebo group as in the saw palmeto group, suggesting other serious health issues might have been present in the population. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Indena and Kanebo Cosmetics present their olive fruit extract OPEXTAN(TM) Company introduces OPEXTAN(TM), an olive fruit extract studied jointly by the Italian company Indena and the Japanese Kanebo Cosmetics Inc. One of the most characteristic olive polyphenols, Verbascoside, exerts a free radical scavenging activity, has been used as the reference compound in the manufacture of the product. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Vitiva Announces New Alliance with FIT Limited Vitiva has announced an alliance with Food Ingredient Technology (FIT), UK, under which FIT will market Vitiva’s rosemary extracts line to the food and dietary supplements markets in the UK and Ireland. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	BioGaia AB has signed a global exclusivity agreement with Novartis Consumer Health SA of Switzerland. The agreement gives Novartis rights within the medical nutrition industry to use BioGaia's health bacteria, Reuteri, and BioGaia's delivery technologies. The agreement is to be implemented by Novartis Medical Nutrition a business unit of Novartis Consumer Health SA. Novartis Medical Nutrition had a turnover in 2004 of 1.12 billion USD. Novartis Medical Nutrition offers a complete range of oral nutrition and enteral tube feeding products and devices tailored to the needs of consumers, patients and healthcare professionals. Under the agreement, Novartis will develop and launch medical nutrition products incorporating Reuteri and BioGaia's existing delivery technology, and the two organisations will cooperate to develop new products especially adapted for the this market. "We are very happy and proud to announce that Novartis Medical Nutrition has chosen to enter into a long term collaboration with BioGaia for our Reuteri and delivery technologies. Our outstanding clinical results and unique products form the foundations for this breakthrough within medical nutrition," said Peter Rothschild, Managing Director for BioGaia AB. BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health effects. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic or health-enhancing effects. The Parent Company BioGaia AB's class B share is quoted on the O list of the Stockholm Stock Exchange.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software